KBC Group NV »

Newamsterdam Pharma Co Nv shares owned by KBC Group NV

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by KBC Group NV

Quarter filed Position value Share count Share price at filing
2026-03-31 $37k 1.2k 31.60

More positions owned by KBC Group NV

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Bank of America Corporation (BAC)
Citigroup Com New (C)
Gilead Sciences (GILD)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)

View all positions for KBC Group NV

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Capital World Investors
RA Capital Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
FMR
Wellington Management Company
Deerfield Management Company
Viking Global Investors
Duquesne Family Office
Polar Capital Holdings
Jennison Associates
Medicxi Ventures Management
Henderson Group
Westfield Capital Management Company

View all funds holding Newamsterdam Pharma Co Nv